跳至主要内容
临床试验/NCT04515992
NCT04515992已完成不适用

Feasibility of Minimal Dose High Intensity Body-weight Circuit Training in Type 2 Diabetics

Kennesaw State University2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6
试验地点
2
主要终点
Change from baseline of HbA1c

研究概览

简要总结

Exercise has been shown to be effective at improving fitness, as well as markers of glucose tolerance and control, in persons with type 2 diabetes. Recently, several investigations have demonstrated that improvements are realized by patients with high intensity interval exercise which is characterized by periods of vigorous exercise alternated by periods of moderate exercise. Typical interval training sessions require significantly less time to complete than traditional modes of exercise wherein moderate intensity activity is sustained for some time. This may be especially beneficial to those with type 2 diabetes, as lack of time is a frequently cited reason for not engaging in regular exercise. Bodyweight circuit training carries the potential to similarly improve health and metabolic function in persons with type 2 diabetes, and may do so with even a smaller accumulation of exercise because this type of exercise involves a greater percentage of the trainee's muscle mass compared with common forms of interval training (e.g., treadmill or cycle exercise). The purpose of this study is to quantify the effects of 3-4 sessions per week of bodyweight circuit training sustained for 5-10 minutes per session on health-related physical fitness and glucose tolerance/control in people with type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Type 2 Diabetes of at least 1 year
  • hemoglobin A1c level between 6.0% and 10%

排除标准

  • Currently engaging in a physical activity
  • Currently taking exogenous insulin
  • Undertaking a regiment or lifestyle modification intervention.
  • Cardiovascular or Pulmonary diseases.

结局指标

主要结局

Change from baseline of HbA1c

时间窗: 16 weeks

glycosylated hemoglobin, marker of approximate three month blood glucose environment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验